Massachusetts H 1347: An Act relative to Group Health Insurance Commission
Status: Accompanied a study order, see H4654 (as of 2018-06-25)
State: Massachusetts · Session: 190th · Bill: H 1347
Sponsors: Tackey Chan, Raymond McGrath
Bill Text
1 of 1 HOUSE DOCKET, NO. 915 FILED ON: 1/14/2025 HOUSE . . . . . . . . . . . . . . . No. 1347 The Commonwealth of Massachusetts _________________ PRESENTED BY: Bud L. Williams _________________ To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General Court assembled: The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill: An Act to improve sickle cell care. _______________ PETITION OF: NAME: DISTRICT/ADDRESS: DATE ADDED: Bud L. Williams 11th Hampden 1/14/2025 1 of 22 HOUSE DOCKET, NO. 915 FILED ON: 1/14/2025 HOUSE . . . . . . . . . . . . . . . No. 1347 By Representative Williams of Springfield, a petition (accompanied by bill, House, No. 1347) of Bud L. Williams relative to sickle cell care. Financial Services. The Commonwealth of Massachusetts _______________ In the One Hundred and Ninety-Fourth General Court (2025-2026) _______________ An Act to improve sickle cell care. Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows: 1 Chapter 118E of the General Laws is hereby amended by inserting after section 10Q, the 2 following section: 3 Section 10R. (a) For the purposes of this section, the following words shall have the 4 following meanings unless the context clearly requires otherwise: 5 “Directly or indirectly cause impairment of fertility”, to cause circumstances where a 6 disease or the necessary treatment for a disease has a likely side effect of infertility as established 7 by the American Society for Reproductive Medicine, the American Society of Clinical Oncology 8 or other reputable professional organizations. 9 “Standard fertility preservation services”, procedures or treatments to preserve fertility as 10 recommended by a board-certified obstetrician gynecologist, reproductive endocrinologist or 11 other physician; provided, however, that the recommendation shall be made in accordance with 12 current medical practices and professional guidelines published by the American Society for 2 of 22 13 Reproductive Medicine, the American Society of Clinical Oncology or other reputable 14 professional organizations. 15 (b) The division and its contracted health insurers, health plans, health maintenance 16 organizations, behavioral health management firms and third-party administrators under contract 17 to a Medicaid managed care organization or primary care clinician plan shall provide coverage 18 for standard fertility preservation services, including, but not limited to, coverage for 19 procurement, cryopreservation and storage of gametes, embryos or other reproductive tissue, 20 when the covered person has a diagnosed medical or genetic condition that may directly or 21 indirectly cause impairment of fertility by affecting reproductive organs or processes. Coverage 22 shall be provided to the same extent that coverage is provided for other pregnancy-related 23 procedures. 24 STATEWIDE SCD STEERING COMMITTEE 25 SECTION 3. (a)(1) Notwithstanding any general or special law to the contrary, there is 26 hereby established a Statewide Steering Committee on Sickle Cell Disease within the department 27 of public health. 28 (2) The Steering Committee under this section shall consist of: 29 (A) two representatives from the Massachusetts Sickle Cell Disease Association 30 including the Executive Director or their designee; 31 (B) three medical professionals from major Sickle Cell Disease treatment centers in the 32 commonwealth who shall be appointed by the commissioner; 3 of 22 33 (C) the Executive Director of the Massachusetts Association of Community Health 34 Workers or their designee; 35 (D) the President of the Massachusetts Chapter of the National Association of Social 36 Workers or their designee; 37 (E) two members who shall be appointed by the commissioner, one of whom shall be an 38 expert on the biology of the disease, and one of whom shall be an expert on the psycho-social 39 aspect of the disease; 40 (F) two representatives of the department of elementary and secondary education who 41 shall be appointed by the commissioner, including one of whom is knowledgeable about the right 42 to comparable education, supportive services and accommodations under section 504 of the 43 Rehabilitation Act of 1973; 44 (G) one representative of the Black and Latino Caucus who shall be appointed by the 45 commissioner; 46 (H) one representative of the Asian Caucus who shall be appointed by the commissioner; 47 (I) two sickle cell disease patients who shall be appointed by the Governor, one of which 48 shall be over 25 years in age and the other shall be between 18 and 25 years in age; 49 (J) a parent of a minor child with sickle cell disease who shall be appointed by the 50 Governor; 51 (K) a parent of a secondary or post-secondary school age youth with sickle cell disease 52 who shall be appointed by the commissioner; and 4 of 22 53 (
View Massachusetts H 1347 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.